Marshall Wace’s Science Strategic Acquisition Corp. Alpha Class A Common Stock SSAA Stock Holding History

Marshall Wace’s Portfolio SSAA Stock Details SSAA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,478,821	Closed	-$14.6M	–	3772
2022 Q3	$14.6M	Hold	1,478,821	–	–	0.03%	615
2022 Q2	$14.5M	Hold	1,478,821	–	–	0.03%	640
2022 Q1	$14.5M	Buy	1,478,821 +123,140	+9%	+$1.2M	0.03%	634
2021 Q4	$13.2M	Buy	1,355,681 +471,743	+53%	+$4.61M	0.02%	678
2021 Q3	$8.58M	Buy	883,938 +184,275	+26%	+$1.79M	0.04%	644
2021 Q2	$6.77M	Buy	+699,663	New	+$6.84M	0.03%	675

Marshall Wace's SSAA Position: Q4 2022 in Review

Marshall Wace sold out of Science Strategic Acquisition Corp. Alpha Class A Common Stock (SSAA) in Q4 2022, closing a stake of 1,478,821 shares — an estimated $14.6M sold.

Marshall Wace first reported a position in SSAA in Q2 2021 and held it in 6 quarters. The position peaked at $14.6M in Q3 2022. 0 funds tracked by Wall St. Rank hold SSAA as of Q4 2022.

Marshall Wace reported no remaining Science Strategic Acquisition Corp. Alpha Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Marshall Wace sold 1,478,821 Science Strategic Acquisition Corp. Alpha Class A Common Stock shares in Q4 2022, an estimated $14.6M.
Marshall Wace first reported a position in Science Strategic Acquisition Corp. Alpha Class A Common Stock in Q2 2021 and held it in 6 quarters.
Marshall Wace's Science Strategic Acquisition Corp. Alpha Class A Common Stock position peaked at $14.6M in Q3 2022.
0 funds tracked by Wall St. Rank held Science Strategic Acquisition Corp. Alpha Class A Common Stock as of Q4 2022.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.